Longevity Supplements for Men Over 40: What the Evidence Actually Supports (2026)
At 42, you are not the same organism you were at 32. This is not motivational speaker rhetoric. It is measurable biology.
Your total testosterone is declining at roughly 1.6% per year. Your free testosterone — the fraction that actually does things — is falling at 2-3% annually because sex hormone-binding globulin (SHBG, a protein that binds testosterone and renders it inactive) is rising simultaneously. Your NAD+ levels (the coenzyme required for cellular energy production and DNA repair) are dropping. Your cardiovascular risk is climbing on a trajectory that will make heart disease your most likely cause of death. And you are losing roughly 3-8% of your muscle mass per decade, a process that accelerates after 50.
None of this is inevitable in its severity. But addressing it requires understanding what is actually happening — not what supplement companies want you to believe is happening.
Men age differently than women after 40. Where women face the acute hormonal cliff of menopause (see Longevity for Women Over 40: Perimenopause and Cellular Aging), men experience a slower, grinding decline across multiple systems simultaneously. The cardiovascular system takes the hardest hit earliest. And unlike women, men have no cultural framework for discussing age-related hormonal decline — which means most men do nothing until something breaks.
This article covers what the clinical evidence actually supports for men over 40 — the supplements with real data, the ones with overhyped marketing, and the lifestyle interventions that no pill can replace.
TL;DR — Key Takeaways
- Total testosterone declines ~1.6% per year after 30; free testosterone drops 2-3% annually due to rising SHBG (Harman et al., 2001, Baltimore Longitudinal Study of Aging)
- Men die ~5 years earlier than women on average, primarily driven by cardiovascular disease — which begins accumulating silently in the 40s
- NAD+ decline is tissue-specific and accelerates after 40, making NAD+ precursors like NMN increasingly relevant (McReynolds et al., 2020)
- Creatine has the strongest evidence of any supplement for preserving muscle mass and strength in aging men — and emerging data for brain health
- Prostate health compounds (saw palmetto, lycopene, zinc) have mixed evidence — lycopene shows the most consistent data, saw palmetto failed rigorous trials
- Resistance training is the single most effective intervention for testosterone, muscle preservation, cardiovascular risk, and all-cause mortality — no supplement replaces it
- Magnesium, vitamin D, and omega-3 are foundational — most men over 40 are deficient in all three
- Protein intake needs to increase with age due to anabolic resistance (reduced efficiency of muscle protein synthesis per gram consumed)
The Male Aging Timeline: What Changes After 40
Men's biological aging is not a single event. It is a convergence of declining systems, each on its own timeline but all accelerating in the fourth and fifth decades.
Testosterone decline begins earlier than most men realize. The Baltimore Longitudinal Study of Aging (Harman et al., Journal of Clinical Endocrinology & Metabolism, 2001, PMID 11158037) — one of the longest-running studies of aging in America — documented that total testosterone declines approximately 0.124 nmol/L per year, with roughly 20% of men over 60, 30% over 70, and 50% over 80 meeting criteria for hypogonadism (clinically low testosterone). Critically, this decline is independent of illness — age itself drives it.
But total testosterone only tells part of the story. SHBG rises with age, binding more circulating testosterone and reducing the bioavailable fraction. A study published in the Journal of Clinical Endocrinology & Metabolism using Baltimore Longitudinal Study data found that bioavailable testosterone declines linearly across the adult lifespan, with the rate of decline steepening after 40. The result: even men with "normal" total testosterone may have functionally low free testosterone.
The mechanisms behind testosterone decline involve multiple failures occurring simultaneously: Leydig cell function in the testes deteriorates, the hypothalamic-pituitary-gonadal axis (the hormonal feedback loop connecting the brain to the testes) loses sensitivity, SHBG production increases in the liver, and chronic inflammation further suppresses testosterone production.
What this means practically:
- Early 40s: Subtle shifts in body composition (more visceral fat, less muscle at the same weight), slower recovery from exercise, mildly reduced energy. Most blood panels still show "normal" ranges.
- Late 40s to early 50s: The decline becomes measurable and often symptomatic. Reduced libido, less spontaneous morning erections, noticeable strength plateaus despite consistent training, disrupted sleep architecture.
- Late 50s and beyond: ~25% of men have biochemically low testosterone. Muscle loss accelerates. Cardiovascular risk factors that were accumulating silently for a decade begin manifesting as events. Bone density — rarely discussed in men — starts declining measurably.
Key Takeaway: Male hormonal decline is not a single event like menopause — it is a gradual, multi-system process that begins in the 30s and accelerates after 40. The combination of falling testosterone, rising SHBG, and declining NAD+ creates a compounding effect that requires intervention across multiple pathways, not a single "testosterone booster."
The Cardiovascular Imperative: Why Heart Disease Kills Men First
Here is a statistic that should reframe how every man over 40 thinks about longevity: men die approximately 5 years earlier than women, and cardiovascular disease is the primary driver of that gap.
A study examining sex differences in mortality published in Demography found that cardiovascular disease was the second largest contributor to the sex difference in years of potential life lost — accounting for approximately 23-29% of the male-female mortality gap depending on the population studied. Men develop coronary artery disease roughly 10 years earlier than women, lose the cardiovascular protection that women receive from estrogen, and have higher rates of sudden cardiac death at every age.
The 40s are when this trajectory is set. Autopsy studies have shown that atherosclerosis (the buildup of fatty plaques inside artery walls) is already present in 58% of people aged 40-49. The plaques are forming silently. By the time symptoms appear — chest pain, shortness of breath, an actual cardiac event — decades of damage have already accumulated.
What accelerates cardiovascular risk in men over 40:
- Rising LDL and triglycerides — lipid metabolism shifts as testosterone declines and visceral fat increases
- Increased blood pressure — vascular stiffness increases with age, and declining nitric oxide (a signaling molecule that relaxes blood vessels) production reduces arterial flexibility
- Chronic low-grade inflammation — measured by hs-CRP (high-sensitivity C-reactive protein, a blood marker of systemic inflammation), which rises with visceral fat accumulation and poor sleep
- Insulin resistance — abdominal fat is metabolically active tissue that promotes insulin resistance, creating a feed-forward cycle with further fat accumulation
This is why the supplement strategy for men over 40 must prioritize cardiovascular protection — not because it is glamorous, but because it is the system most likely to kill you.
For the complete evidence on how omega-3 fatty acids address multiple cardiovascular risk pathways, see Omega-3 and Longevity: The Evidence Goes Far Beyond Heart Health.
Foundational Supplements: The Evidence-Based Core
These are not exotic longevity compounds. They are basic nutritional deficits that most men over 40 carry — and correcting them has the highest return on investment of any supplementation strategy.
Omega-3 Fatty Acids (EPA and DHA)
The evidence: A 2021 meta-analysis by Khan et al. in EClinicalMedicine (PMID 34505026), covering 38 randomized controlled trials and 149,051 participants, found that omega-3 supplementation reduced cardiovascular mortality (RR 0.93), non-fatal myocardial infarction (RR 0.87), and coronary heart disease events (RR 0.91). EPA monotherapy showed stronger effects than EPA+DHA combinations.
For triglyceride reduction specifically — a key concern as men's lipid profiles shift after 40 — the American Heart Association notes that 3-4g EPA+DHA daily can reduce triglyceride levels by 20-50% in individuals with elevated levels.
Practical dose: 2-3g combined EPA+DHA daily. Prioritize EPA content if cardiovascular risk is your primary concern.
Vitamin D
The problem is enormous: Over 42% of U.S. adults are vitamin D insufficient, and men over 40 are disproportionately affected because they spend less time outdoors as careers and family obligations peak, and skin synthesis efficiency declines with age.
The intersection of vitamin D and testosterone is particularly relevant. A 2011 randomized controlled trial by Pilz et al. in Hormone and Metabolic Research (PMID 21154195) found that vitamin D-deficient men who supplemented for one year saw total testosterone increase from approximately 10.7 to 13.4 nmol/L — a 25% increase — while the placebo group showed no change. A 2023 systematic review confirmed a positive association between vitamin D levels and total testosterone, particularly in men who were deficient at baseline.
Beyond testosterone, the combination of low free testosterone and low vitamin D predicts increased all-cause and cardiovascular mortality in men (Lerchbaum et al., Clinical Endocrinology, 2012, PMID 22356136).
Practical dose: 2,000-5,000 IU daily, titrated to blood levels of 40-60 ng/mL. Test first — supplementing without knowing your baseline is guessing. For the full vitamin D evidence, see Vitamin D and Aging: Why 42% of Americans Are Deficient.
Magnesium
Magnesium is involved in over 300 enzymatic reactions, and approximately 48% of Americans do not meet the RDA from diet alone. For men over 40, it is triply relevant: cardiovascular function, sleep quality, and testosterone support.
Maggio et al. (2011) studied 399 men aged 65+ and found that serum magnesium levels were "strongly and independently associated with the anabolic hormones testosterone and IGF-1" (International Journal of Andrology, PMID 21675994). A separate study by Cinar et al. (2011, PMID 20352370) demonstrated that magnesium supplementation increased free and total testosterone in both athletes and sedentary men, with the effect amplified by exercise.
For cardiovascular protection, a 2016 meta-analysis found magnesium supplementation of 300+ mg/day reduced systolic blood pressure by 2 mmHg and diastolic by 1.78 mmHg (Zhang et al., Hypertension, PMID 27402922). Modest but consistent — and magnesium deficiency is a correctable risk factor.
Practical dose: 200-400 mg elemental magnesium daily. Glycinate or threonate forms for sleep benefit; citrate for general use. See Magnesium and Longevity: The Most Deficient Mineral in the Modern Diet.
Muscle Preservation: The Longevity Insurance Policy
Sarcopenia (age-related loss of muscle mass and strength) is not a cosmetic concern. It is a mortality risk factor. Muscle mass decreases approximately 3-8% per decade after age 30, and strength declines even faster — roughly 1.5% per year between ages 50 and 60, accelerating to 3% per year thereafter.
For men, this matters beyond aesthetics because skeletal muscle is the body's largest glucose disposal site, a primary determinant of metabolic rate, and — as recent research confirms — an endocrine organ that produces myokines (signaling molecules released by contracting muscle that exert anti-inflammatory and metabolic effects throughout the body). Losing muscle means losing metabolic resilience.
Creatine: The Most Underrated Longevity Supplement for Men
Creatine is not just for bodybuilders. It may be the single best-supported supplement for aging men.
A 2014 meta-analysis by Devries and Phillips in Medicine & Science in Sports & Exercise (PMID 24576864) examined 357 older adults (average age ~64) and found that adding creatine to resistance training produced:
- Greater increases in fat-free muscle mass compared to resistance training alone
- Greater improvements in chest press and leg press strength
- Better performance on the 30-second chair stand test — a direct measure of functional capacity and fall risk
A more recent systematic review confirmed that creatine plus resistance training improves lower extremity strength and lean tissue mass, with optimal effects at doses of 5g/day or higher.
Beyond muscle, creatine supports brain energy metabolism. The brain consumes roughly 20% of the body's energy despite comprising only 2% of body weight, and creatine serves as an ATP (adenosine triphosphate — the energy currency of cells) buffer in neural tissue. For the full cognitive evidence, see Creatine Beyond Muscle: Brain Health, Mitochondria, and Aging.
Practical dose: 3-5g creatine monohydrate daily. No loading phase necessary. No cycling required. Safe in long-term use with no evidence of kidney harm in healthy adults.
Protein: More Than You Think
The RDA for protein (0.8g/kg body weight) was set to prevent deficiency, not to optimize muscle preservation in aging adults. Current evidence strongly supports higher intakes.
Paddon-Jones and Rasmussen (2009, Current Opinion in Clinical Nutrition and Metabolic Care, PMID 19057193) established that approximately 25-30g of high-quality protein per meal is necessary to maximally stimulate muscle protein synthesis (MPS) — the process by which your body builds new muscle tissue. Below ~20g per meal, MPS is significantly diminished.
The concept of anabolic resistance is critical for men over 40: aged muscle requires a higher protein dose to achieve the same MPS response as younger muscle. This is why the ESPEN Expert Group recommends 1.0-1.2g/kg/day for healthy older adults, with 1.2-1.5g/kg/day for those doing resistance training or recovering from illness.
For a 85 kg (187 lb) man over 40 doing resistance training, that is 102-128g of protein per day — distributed across 3-4 meals of 25-35g each. Most men in this demographic consume 70-80g.
| Protein Strategy | Daily Target | Per-Meal Target | Best For |
|---|---|---|---|
| Minimum (sedentary) | 0.8-1.0 g/kg | 20-25g | Preventing deficiency |
| Moderate (active) | 1.2-1.5 g/kg | 25-30g | Maintaining muscle |
| Optimal (resistance training) | 1.5-1.8 g/kg | 30-40g | Building/preserving muscle after 40 |
| High (over 60 + training) | 1.6-2.0 g/kg | 35-45g | Combating anabolic resistance |
Key Takeaway: Creatine plus adequate protein (1.2-1.5g/kg/day, distributed evenly across meals) is the highest-evidence supplement strategy for preserving muscle mass and strength after 40. But neither works without resistance training — the stimulus that tells your body to actually use these substrates for muscle rather than converting them to energy.
NAD+ and Cellular Energy: The Decline That Drives Everything
NAD+ (nicotinamide adenine dinucleotide) is a coenzyme required for hundreds of metabolic reactions, including mitochondrial energy production, DNA repair via PARP enzymes (proteins that detect and repair DNA damage), and sirtuin activation (a family of proteins that regulate cellular health, gene expression, and stress resistance). NAD+ levels decline with age, and this decline is increasingly recognized as a driver — not merely a consequence — of aging.
McReynolds, Chellappa, and Baur (2020) published a comprehensive review in Experimental Gerontology (PMID 32097708) documenting that NAD+ concentrations decline in aged tissues through multiple mechanisms: increased consumption by CD38 (an enzyme that breaks down NAD+ and increases with chronic inflammation), reduced synthesis, and cellular composition changes including fat cell accumulation in tissues that were previously NAD+-rich.
The men-specific angle: While NAD+ decline is universal, the practical consequences hit men through a particular channel — mitochondrial dysfunction compounds with testosterone decline. Testosterone supports mitochondrial biogenesis (the creation of new mitochondria) through androgen receptor signaling, and NAD+ is required for mitochondrial function. When both decline simultaneously, cellular energy production takes a double hit.
NMN: The Evidence So Far
NMN (nicotinamide mononucleotide) is a direct precursor to NAD+. The clinical evidence in humans has matured significantly since 2021.
Key trials relevant to men:
- Yi et al. (2023) conducted a multicenter, double-blind, placebo-controlled trial of 300-900mg NMN daily in healthy middle-aged adults (GeroScience, PMID 36482258). Results: significantly elevated blood NAD+ at all doses, improved six-minute walking distance, and stabilized biological age (measured by epigenetic clocks) while the placebo group showed age acceleration. Optimal dose: 600mg/day.
- Igarashi et al. (2022) studied 250mg NMN daily for 12 weeks in healthy older men (NPJ Aging, PMID 35927255). Results: significantly elevated blood NAD+ and NAD+ metabolites, nominally significant improvements in gait speed and grip strength. No adverse effects.
NMN is not a testosterone booster or a muscle builder. Its role in the men-over-40 stack is foundational — supporting the cellular energy infrastructure that every other system depends on. For the complete science, see What Is NMN and Why Does NAD+ Decline With Age?.
Practical dose: 250-600mg NMN daily, taken in the morning.
Prostate Health: Separating Evidence From Marketing
By age 50, roughly half of men will have some degree of benign prostatic hyperplasia (BPH — non-cancerous enlargement of the prostate gland). By 80, that figure rises to approximately 90%. Prostate health is a legitimate concern for men over 40 — and it is also one of the most exploited categories in supplement marketing.
Here is what the evidence actually shows:
Saw Palmetto: The Disappointment
Saw palmetto (Serenoa repens) is the most commonly used herbal supplement for prostate health. Early systematic reviews suggested it improved urinary symptoms and flow rates comparably to finasteride (a prescription drug for BPH).
Then came rigorous trials. The CAMUS trial (Barry et al., JAMA, 2011, PMID 21954478) — a double-blind, multicenter, placebo-controlled randomized trial of 369 men — tested increasing doses of saw palmetto extract (up to 960mg/day) over 72 weeks. The result: saw palmetto did not reduce lower urinary tract symptoms more than placebo at any dose.
This does not mean the earlier positive studies were fabricated. It means they had methodological limitations (smaller samples, shorter durations, less rigorous controls) that the CAMUS trial corrected. The current evidence does not support saw palmetto for prostate health.
Lycopene: Modest but Consistent
Lycopene (a carotenoid pigment found in high concentrations in tomatoes, watermelon, and pink grapefruit) has the most consistent observational evidence for prostate cancer risk reduction.
Rowles et al. (2017) published a systematic review and meta-analysis in Prostate Cancer and Prostatic Diseases (PMID 28440323) covering 42 studies with 43,851 prostate cancer cases from 692,012 participants. Findings:
- Both dietary intake and circulating lycopene were significantly associated with reduced prostate cancer risk (RR = 0.88 for both)
- Risk decreased by 1% for every additional 2mg of dietary lycopene consumed
- Risk decreased by 3.5% for each additional 10 mcg/dL of circulating lycopene
The important caveat: This is observational data. Men who eat more lycopene-rich foods also tend to have healthier overall diets. The association is real and consistent, but causation from supplementation alone has not been established through randomized controlled trials. There was no significant association with advanced prostate cancer.
Practical approach: Prioritize dietary lycopene (cooked tomatoes — heat increases bioavailability — watermelon, pink grapefruit) over supplements. If supplementing, 10-30mg/day is the typical range used in studies.
Zinc: Important but Double-Edged
The prostate gland accumulates zinc at concentrations 10 times higher than other soft tissues. Zinc is essential for prostate cell function, and zinc deficiency is associated with both BPH and increased prostate cancer risk.
A systematic review by Te et al. (2023, Journal of Trace Elements in Medicine and Biology, PMID 36577241) confirmed that zinc deficiency reduces testosterone levels and zinc supplementation improves testosterone levels, with the effect depending on baseline zinc status.
The classic study by Prasad et al. (1996, Nutrition, PMID 8875519) demonstrated this directly: restricting dietary zinc in young men for 20 weeks caused testosterone to drop significantly, while supplementing zinc-deficient elderly men for six months raised it.
The caution: Excessive zinc supplementation (above 40mg/day) can cause copper depletion, gastrointestinal distress, and — paradoxically — may increase prostate cancer risk at very high doses. More is not better.
Practical dose: 15-30mg zinc daily if dietary intake is low (common in men who do not regularly eat red meat, shellfish, or pumpkin seeds). Always pair with 1-2mg copper to prevent depletion.
How key prostate-health compounds compare:
| Compound | Evidence Level | Key Finding | Recommended? |
|---|---|---|---|
| Saw Palmetto | Weak (failed RCTs) | No better than placebo in CAMUS trial | No |
| Lycopene | Moderate (observational) | 12% reduced prostate cancer risk in meta-analysis | Yes (dietary first) |
| Zinc | Moderate (clinical) | Supports testosterone; essential for prostate function | Yes (15-30mg/day) |
| Beta-Sitosterol | Moderate (small RCTs) | May improve urinary symptoms in BPH | Maybe (needs larger trials) |
| Selenium | Weak (failed RCT) | SELECT trial showed no prostate cancer benefit | No |
Key Takeaway: The prostate supplement market is built largely on hope rather than evidence. Saw palmetto — the most popular option — failed the most rigorous clinical trial ever conducted on it. Lycopene from dietary sources and adequate zinc (not excessive) are the evidence-supported strategies. Skip the "prostate formula" products charging premium prices for ingredients that do not work.
Resistance Training: The Non-Negotiable Foundation
No supplement discussion for men over 40 is complete without stating clearly: resistance training is the single most effective intervention available for nearly every aging pathway discussed in this article. It is not optional. It is the foundation upon which supplements provide marginal additional benefit.
The evidence is not subtle. A 2022 systematic review and meta-analysis by Shailendra et al. in the American Journal of Preventive Medicine (PMID 35599175) analyzed 10 studies and found:
- 15% reduced risk of all-cause mortality with any resistance training
- 19% reduced risk of cardiovascular disease mortality
- 14% reduced risk of cancer-specific mortality
- Maximum risk reduction of 27% at approximately 60 minutes per week
When combined with aerobic exercise, resistance training was associated with a 40% reduction in all-cause mortality compared to no exercise. No supplement comes close to this effect size.
What resistance training does that supplements cannot:
- Directly stimulates muscle protein synthesis through mechanotransduction (the process by which mechanical force on muscle fibers triggers anabolic signaling cascades)
- Acutely increases testosterone and growth hormone — each training session produces a hormonal pulse that promotes muscle maintenance
- Improves insulin sensitivity by increasing glucose uptake into muscle tissue (the body's largest glucose sink)
- Loads bone, stimulating osteoblast (bone-building cell) activity and maintaining bone density — a concern for men that is drastically under-discussed
- Reduces visceral fat more effectively than cardio alone in middle-aged men
- Produces myokines that exert anti-inflammatory effects throughout the body
Minimum effective dose for men over 40: 2-3 sessions per week, focusing on compound movements (squats, deadlifts, rows, presses, hinges) at challenging loads. Progressive overload (gradually increasing weight, volume, or intensity) is the key principle. For the complete exercise-longevity evidence base, see Strength Training for Longevity: Why Muscle Is a Survival Organ.
Zone 2 cardio (sustained moderate intensity where you can hold a conversation, typically 60-70% max heart rate) should complement resistance training at 150+ minutes per week for mitochondrial health and cardiovascular fitness. VO2 max (maximal oxygen consumption during exercise) is the single strongest predictor of all-cause mortality, and it declines approximately 10% per decade without intervention.
The Complete Men's Supplement Stack (By Priority)
Not every man over 40 needs every supplement. Here is the evidence-based hierarchy, organized by the strength of evidence and the breadth of benefit.
Tier 1: Correct Deficiencies First (Highest ROI)
These address widespread nutritional gaps that undermine everything else:
| Supplement | Dose | Why It Matters | Test First? |
|---|---|---|---|
| Vitamin D3 | 2,000-5,000 IU/day | Testosterone support, bone, cardiovascular, immune | Yes (25(OH)D blood test) |
| Magnesium | 200-400 mg/day | Testosterone, sleep, blood pressure, 300+ enzymatic reactions | Optional (serum Mg is unreliable) |
| Omega-3 (EPA/DHA) | 2-3g/day | Cardiovascular protection, triglycerides, inflammation | Optional (omega-3 index test) |
| Zinc | 15-30 mg/day | Testosterone, prostate function, immune | Optional (serum zinc) |
Tier 2: Muscle and Performance (Strong Evidence)
These have robust clinical trial data for aging men specifically:
- Creatine monohydrate: 3-5g/day — muscle preservation, strength, brain energy
- Protein: 1.2-1.8g/kg/day from diet + supplementation as needed — muscle protein synthesis, satiety, metabolic rate
Tier 3: Cellular Aging (Emerging Evidence)
These target underlying aging mechanisms with growing but still-maturing human data:
- NMN: 250-600mg/day — NAD+ repletion, cellular energy, emerging physical function data
- CoQ10 (ubiquinol form): 100-200mg/day — mitochondrial support, cardiovascular function. CoQ10 production declines approximately 50% between ages 25 and 65. For the mechanism, see CoQ10 Ubiquinol: The Mitochondrial Fuel Your Body Stops Making After 40.
Tier 4: Targeted Concerns (Situational)
Add based on individual risk factors or symptoms:
- Lycopene: 10-30mg/day or dietary emphasis — prostate cancer risk reduction (if family history or concern)
- Fiber (psyllium): 10-15g/day — cardiovascular risk reduction, gut health, often overlooked by men
- Vitamin K2 (MK-7): 180-200 mcg/day — directs calcium to bones rather than arteries (particularly relevant if supplementing vitamin D and calcium)
Key Takeaway: Start with Tier 1 — correcting deficiencies — before spending money on exotic compounds. A man with low vitamin D, inadequate magnesium, insufficient protein, and no resistance training program will not benefit meaningfully from NMN or CoQ10. Fix the foundation first.
What Not to Waste Money On
The men's supplement market is enormous and largely built on insecurity rather than evidence. Here are the categories where marketing dramatically exceeds science:
"Testosterone boosters" (tribulus, fenugreek, D-aspartic acid, DHEA): The vast majority of over-the-counter testosterone boosters have either failed controlled trials or produced changes too small to be clinically meaningful. A few (like ashwagandha) show modest cortisol-lowering effects that may indirectly support testosterone, but the magnitude is nothing like what the marketing implies.
Mega-dose antioxidants (vitamin C 1000mg+, vitamin E 400 IU+): The SELECT trial found that vitamin E supplementation at 400 IU/day actually increased prostate cancer risk by 17% in men. High-dose antioxidant supplementation can blunt the hormetic (beneficial stress) signaling from exercise. More is not better.
Saw palmetto prostate formulas: As discussed above, the most rigorous clinical trial found no benefit over placebo. The continued marketing of saw palmetto is a triumph of tradition over evidence.
Single-ingredient "longevity" supplements at inadequate doses: Many products contain a sprinkling of multiple compounds — 50mg CoQ10, 100mg NMN, 5mg resveratrol — at doses far below what clinical trials used. Underdosing is a form of not taking the supplement at all.
Frequently Asked Questions
Q: At what age should men start taking longevity supplements?
The foundational three — vitamin D, magnesium, and omega-3 — benefit men at any age and should be considered from 30 onward based on blood testing. Creatine and higher protein intake become increasingly important from 35-40 as anabolic resistance begins. NAD+ precursors like NMN have the most relevance from 40+, when NAD+ decline becomes more pronounced and downstream consequences (energy, recovery, cardiovascular risk) become measurable.
Q: Can supplements actually raise testosterone?
Correcting deficiencies can. Vitamin D supplementation raised testosterone by ~25% in deficient men (Pilz et al., 2011). Zinc supplementation restored testosterone in zinc-restricted men (Prasad et al., 1996). Magnesium is independently associated with higher testosterone in older men (Maggio et al., 2011). But these effects depend on being deficient in the first place. If your levels are already adequate, supplementation will not push testosterone above your biological set point. No legal over-the-counter supplement will produce the testosterone increases that marketing materials imply.
Q: Is NMN safe for long-term use?
Current evidence from human trials of up to 12 weeks shows no safety concerns at doses up to 900mg/day. The Yi et al. (2023) multicenter trial found NMN was "well tolerated" with no significant adverse events. However, long-term (multi-year) safety data in humans does not yet exist. NMN has been used in research settings and by early adopters since approximately 2018 without reported safety signals, but this is observational rather than controlled data.
Q: How much protein is too much? Will it damage my kidneys?
In healthy adults with normal kidney function, there is no evidence that protein intakes up to 2.0g/kg/day cause kidney damage. This is a persistent myth based on observations in people with pre-existing kidney disease, where protein restriction is appropriate. A 2018 meta-analysis in the Journal of Nutrition found no association between high protein intake and kidney function decline in healthy adults. If you have existing kidney disease, consult your physician.
Q: Should I take a PSA test for prostate health?
PSA (prostate-specific antigen) testing is a conversation to have with your physician starting around age 50 (or 40-45 if you have a family history of prostate cancer or are African American). PSA is a screening tool with meaningful false-positive and false-negative rates, so it requires clinical interpretation rather than supplement-based management. No supplement replaces appropriate medical screening.
Q: Does creatine cause hair loss?
A single 2009 study in rugby players suggested creatine increased DHT (dihydrotestosterone — a potent androgen associated with hair follicle miniaturization in genetically susceptible men) by 56%. This study has not been replicated, and multiple subsequent reviews have found no consistent evidence linking creatine to hair loss. If you are genetically predisposed to male pattern baldness, the theoretical concern exists but remains unsubstantiated by the broader evidence base.
Q: What blood tests should men over 40 get for longevity?
At minimum: total and free testosterone, SHBG, 25(OH)D (vitamin D), complete lipid panel (including triglycerides and lipoprotein particle size if available), fasting glucose and insulin (or HbA1c), hs-CRP (inflammation), CBC (complete blood count), comprehensive metabolic panel, and PSA (discuss timing with your doctor). Consider adding: omega-3 index, homocysteine, DEXA scan (body composition and bone density), and ApoB (a superior marker of cardiovascular risk compared to LDL-C alone). For a full guide, see Longevity Blood Tests: What to Track and Why Your Doctor Doesn't Order Them.
Q: How does the men's longevity approach differ from women's?
Women face an acute hormonal transition (menopause) that accelerates biological aging by ~6% and demands immediate bone-protective, cardiovascular, and mitochondrial interventions. Men face a slower, linear decline across testosterone, NAD+, and cardiovascular systems. Men's priorities skew more heavily toward cardiovascular protection (the #1 killer), muscle preservation (faster absolute loss), and prostate health (no female equivalent). Women's priorities emphasize bone density (more acute loss), sleep disruption (menopause-driven), and brain health (higher Alzheimer's risk). The foundational supplements (vitamin D, magnesium, omega-3, creatine, protein) are largely the same. For the women's perspective, see Longevity for Women Over 40: Perimenopause and Cellular Aging.
The Bottom Line: Men over 40 face a convergence of testosterone decline, rising cardiovascular risk, accelerating muscle loss, and falling NAD+ levels. The evidence-based response starts with fixing deficiencies (vitamin D, magnesium, omega-3, zinc), building the anabolic foundation (creatine, adequate protein, resistance training), and then layering cellular aging interventions (NMN, CoQ10) on top. No supplement replaces resistance training — the single intervention with the broadest and strongest mortality data. Skip the testosterone boosters and prostate formulas. Invest in what actually works.
Related Reading
- Longevity Supplements by Age: Your 30s, 40s, and 50s
- Longevity for Women Over 40: Perimenopause and Cellular Aging
- What Is NMN and Why Does NAD+ Decline With Age?
- CoQ10 Ubiquinol: The Mitochondrial Fuel Your Body Stops Making After 40
- Omega-3 and Longevity: The Evidence Goes Far Beyond Heart Health
- Creatine Beyond Muscle: Brain Health, Mitochondria, and Aging
- Strength Training for Longevity: Why Muscle Is a Survival Organ
- Vitamin D and Aging: Why 42% of Americans Are Deficient
Citations:
- Harman SM et al. Longitudinal effects of aging on serum total and free testosterone. J Clin Endocrinol Metab. 2001. PMID 11158037
- McReynolds MR et al. Age-related NAD+ decline. Exp Gerontol. 2020. PMID 32097708
- Yi L et al. NMN efficacy and safety in middle-aged adults. GeroScience. 2023. PMID 36482258
- Igarashi M et al. NMN supplementation in healthy older men. NPJ Aging. 2022. PMID 35927255
- Khan SU et al. Omega-3 fatty acids and cardiovascular outcomes. EClinicalMedicine. 2021. PMID 34505026
- Pilz S et al. Vitamin D supplementation and testosterone. Horm Metab Res. 2011. PMID 21154195
- Lerchbaum E et al. Low free testosterone and low vitamin D predict mortality. Clin Endocrinol. 2012. PMID 22356136
- Maggio M et al. Magnesium and anabolic hormones in older men. Int J Androl. 2011. PMID 21675994
- Cinar V et al. Magnesium supplementation and testosterone. Biol Trace Elem Res. 2011. PMID 20352370
- Devries MC, Phillips SM. Creatine in older adults: a meta-analysis. Med Sci Sports Exerc. 2014. PMID 24576864
- Shailendra P et al. Resistance training and mortality risk. Am J Prev Med. 2022. PMID 35599175
- Rowles JL et al. Lycopene and prostate cancer risk. Prostate Cancer Prostatic Dis. 2017. PMID 28440323
- Te L et al. Zinc and testosterone: systematic review. J Trace Elem Med Biol. 2023. PMID 36577241
- Prasad AS et al. Zinc status and serum testosterone. Nutrition. 1996. PMID 8875519
- Barry MJ et al. CAMUS trial: saw palmetto for BPH. JAMA. 2011. PMID 21954478
- Paddon-Jones D, Rasmussen BB. Protein and sarcopenia prevention. Curr Opin Clin Nutr Metab Care. 2009. PMID 19057193
- Zhang X et al. Magnesium and blood pressure. Hypertension. 2016. PMID 27402922
These statements have not been evaluated by the FDA. This content is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before beginning any supplement protocol.